<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01108900</url>
  </required_header>
  <id_info>
    <org_study_id>A1481271</org_study_id>
    <nct_id>NCT01108900</nct_id>
  </id_info>
  <brief_title>A Study Of The Evaluation Of Patients Opulation With Erectile Dysfunction, Treated With Sildenafil</brief_title>
  <acronym>SURE</acronym>
  <official_title>Non-Interventional, Prospective Study Of the Evaluation Of Patients Population With ED, Treated With Sildenafil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present study, it is planned to observe a population of 100 ED patients treated
      previously with udenafil and for whom their physician decided to switch them to sildenafil
      because of poor udenafil tolerance and/or poor efficacy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To observe the treatment satisfaction of ED patients (sum of questions 13-14 IIEF) that were switched to sildenafil after a previous treatment with udenafil proved ineffective and/or was poorly tolerated.</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate a change of scores of the IIEF (sum of questions 1-5 and 15) and the EHS.</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>Patients with erectile dysfunction (ED)</arm_group_label>
    <description>100 ED patients in the study that were switched to sildenafil after a previous treatment with udenafil proved ineffective and/or was poorly tolerated</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sildenafil</intervention_name>
    <description>tables, 25,50,100 mg, on demand, 1 month</description>
    <arm_group_label>Patients with erectile dysfunction (ED)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        - Patients, aged &gt;18 years and having been switched to sildenafil after a previous
        treatment with udenafil proved ineffective and/or was poorly tolerated. The evaluation of
        udenafil ineffectivness should be performed after attempt intercourse 2 times a week over
        the course of four weeks.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male patients aged â‰¥ 18 years.

          -  Clinical diagnosis of erectile dysfunction supported by a total score of less than or
             equal to 21 according to Sexual Health Inventory-Male (SHI-M).

          -  Patients having a sexual partner throughout the study.

          -  Patients having been switched to sildenafil after a previous treatment with udenafil
             proved ineffective and/or was poorly tolerated. The evaluation of udenafil
             ineffectivness should be performed after attempt intercourse 2 times a week over the
             course of four weeks.

        Exclusion Criteria:

          -  The patients for whom sildenafil is contraindicated according to the Local Product
             Document (LPD). (See appendix D)

          -  The patients for whom sexual activity is not indicated.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A1481271&amp;StudyName=A%20Study%20Of%20The%20Evaluation%20Of%20Patients%20opulation%20With%20Erectile%20Dysfunction%2C%20Treated%20With%20Sildenafil</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2010</study_first_submitted>
  <study_first_submitted_qc>April 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2010</study_first_posted>
  <last_update_submitted>December 16, 2011</last_update_submitted>
  <last_update_submitted_qc>December 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 20, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Erectile Dysfunction udenafil sildenafil treatment satisfaction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sildenafil Citrate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

